• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清尿酸与超重对高血压的交互作用:来自中国健康与营养调查的发现。

Interaction of serum uric acid with overweight on hypertension: findings from the China Health and Nutrition Survey.

机构信息

Division of Cardiology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.

出版信息

BMC Cardiovasc Disord. 2024 Nov 1;24(1):614. doi: 10.1186/s12872-024-04287-y.

DOI:10.1186/s12872-024-04287-y
PMID:39487411
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11529304/
Abstract

BACKGROUND

Both serum uric acid (SUA) levels and body mass index (BMI) are recognized as important risk factors for hypertension. The current study aimed to investigate the interaction effects between SUA levels and overweight (defined as BMI ≥ 24 kg/m in Chinese) on the incidence of hypertension among Chinese adults.

METHODS

1124 hypertensive participants and 7283 non-hypertensive participants, extracted from the China Health and Nutrition Survey (CHNS), were analyzed. Participants were categorized based on their SUA levels and BMI, to investigate the interaction effects between SUA levels and overweight on hypertension.

RESULTS

In comparison with the reference group (BMI < 24 kg/m and in the 1st quintile of SUA), multivariable adjusted analysis demonstrated that the odds ratio (OR) (95% confidence interval, 95% CI) of hypertension for participants with overweight alone was 2.18 (1.41-3.37); for elevated SUA levels alone, the ORs (95% CIs) were 1.57 (1.08-2.30), 1.84 (1.24-2.74), 2.21 (1.47-3.32), and 2.48 (1.55-3.96) across SUA quintiles; and for the combined effect of higher SUA levels and overweight, the ORs (95% CIs) were 3.25 (2.19-4.82), 3.73 (2.51-5.55), 5.17 (3.42-7.80), and 6.21 (4.01-9.60). The relative excess risk due to interaction (RERI) was 3.26 (1.43-5.09) at the 5th quintile of SUA, indicating the presence of additive interaction between overweight and SUA levels on hypertension.

CONCLUSION

Interaction between SUA levels and overweight on hypertension exists specifically at the highest quintile (Q5, > 6.39 mg/dL) of SUA among Chinese adults. Therefore, strategies to lower SUA levels could be considered as a potential approach to mitigate hypertension risk in overweight individuals within this specific subgroup.

摘要

背景

血清尿酸(SUA)水平和体重指数(BMI)均被认为是高血压的重要危险因素。本研究旨在探讨中国成年人中 SUA 水平与超重(BMI≥24kg/m 定义为超重)之间的交互作用对高血压发病的影响。

方法

从中国健康与营养调查(CHNS)中提取了 1124 名高血压患者和 7283 名非高血压患者进行分析。根据 SUA 水平和 BMI 将参与者分为不同组别,以探讨 SUA 水平和超重之间的交互作用对高血压的影响。

结果

与参考组(BMI<24kg/m 且 SUA 处于第 1 五分位)相比,多变量调整分析显示,仅超重的参与者发生高血压的比值比(OR)(95%置信区间,95%CI)为 2.18(1.41-3.37);仅升高的 SUA 水平的 ORs(95% CIs)分别为 1.57(1.08-2.30)、1.84(1.24-2.74)、2.21(1.47-3.32)和 2.48(1.55-3.96),跨越 SUA 五分位数;对于 SUA 水平升高和超重的联合效应,ORs(95% CIs)分别为 3.25(2.19-4.82)、3.73(2.51-5.55)、5.17(3.42-7.80)和 6.21(4.01-9.60)。SUA 五分位数的交互超额相对危险度(RERI)为 3.26(1.43-5.09),表明超重和 SUA 水平对高血压存在附加交互作用。

结论

在中国成年人中,SUA 水平与超重对高血压的交互作用仅在 SUA 的最高五分位数(Q5,>6.39mg/dL)存在。因此,降低 SUA 水平的策略可能被视为减轻该特定亚组中超重个体高血压风险的一种潜在方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9548/11529304/17f0391c1673/12872_2024_4287_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9548/11529304/17f0391c1673/12872_2024_4287_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9548/11529304/17f0391c1673/12872_2024_4287_Fig1_HTML.jpg

相似文献

1
Interaction of serum uric acid with overweight on hypertension: findings from the China Health and Nutrition Survey.血清尿酸与超重对高血压的交互作用:来自中国健康与营养调查的发现。
BMC Cardiovasc Disord. 2024 Nov 1;24(1):614. doi: 10.1186/s12872-024-04287-y.
2
Individual and combined association analysis of famine exposure and serum uric acid with hypertension in the mid-aged and older adult: a population-based cross-sectional study.基于人群的横断面研究:个体和联合暴露于饥荒和血清尿酸与中老年人群高血压的关联分析。
BMC Cardiovasc Disord. 2021 Sep 6;21(1):420. doi: 10.1186/s12872-021-02230-z.
3
Interaction between serum uric acid and triglycerides in relation to blood pressure.尿酸与甘油三酯在血压方面的相互作用。
J Hum Hypertens. 2011 Nov;25(11):686-91. doi: 10.1038/jhh.2010.112. Epub 2010 Dec 16.
4
An observational study on the relationship between serum uric acid and hypertension in a Northern Chinese population aged 45 to 59 years.一项针对45至59岁中国北方人群血清尿酸与高血压关系的观察性研究。
Medicine (Baltimore). 2017 Apr;96(17):e6773. doi: 10.1097/MD.0000000000006773.
5
Association between Body Mass Index and Serum Uric Acid: mediation analysis involving liver enzymes indicators.体重指数与血清尿酸的关系:涉及肝酶指标的中介分析。
BMC Public Health. 2024 Oct 30;24(1):3007. doi: 10.1186/s12889-024-20457-1.
6
Lack of Associations between Elevated Serum Uric Acid and Components of Metabolic Syndrome Such as Hypertension, Dyslipidemia, and T2DM in Overweight and Obese Chinese Adults.超重和肥胖的中国成年人中,血清尿酸升高与高血压、血脂异常和 T2DM 等代谢综合征组分之间无关联。
J Diabetes Res. 2019 Dec 4;2019:3175418. doi: 10.1155/2019/3175418. eCollection 2019.
7
Serum uric acid is not independently associated with plasma renin activity and plasma aldosterone in hypertensive adults.血清尿酸与高血压成人的血浆肾素活性及血浆醛固酮并无独立相关性。
Nutr Metab Cardiovasc Dis. 2017 Apr;27(4):350-359. doi: 10.1016/j.numecd.2016.12.008. Epub 2016 Dec 27.
8
Elevated serum uric acid is associated with incident hypertension in the health according to various contemporary blood pressure guidelines.根据各种当代血压指南,血清尿酸升高与高血压事件有关。
Nutr Metab Cardiovasc Dis. 2021 Apr 9;31(4):1209-1218. doi: 10.1016/j.numecd.2021.01.003. Epub 2021 Jan 12.
9
Markers of Iron Status Are Associated with Risk of Hyperuricemia among Chinese Adults: Nationwide Population-Based Study.铁状态标志物与中国成年人高尿酸血症风险的相关性:全国性基于人群的研究。
Nutrients. 2018 Feb 9;10(2):191. doi: 10.3390/nu10020191.
10
Association between serum uric acid level and hypertension in a Chinese elderly rural population.血清尿酸水平与中国老年农村人口高血压的相关性。
Clin Exp Hypertens. 2017;39(6):505-512. doi: 10.1080/10641963.2016.1259325. Epub 2017 Jul 19.

本文引用的文献

1
Update in uric acid, hypertension, and cardiovascular diseases.尿酸、高血压和心血管疾病的最新进展。
Hypertens Res. 2023 Jul;46(7):1714-1726. doi: 10.1038/s41440-023-01273-3. Epub 2023 Apr 18.
2
Hypertension in China: epidemiology and treatment initiatives.中国高血压:流行病学和治疗措施。
Nat Rev Cardiol. 2023 Aug;20(8):531-545. doi: 10.1038/s41569-022-00829-z. Epub 2023 Jan 11.
3
The dose-response relationship between BMI and hypertension based on restricted cubic spline functions in children and adolescents: A cross-sectional study.
基于限制三次样条函数的儿童和青少年 BMI 与高血压之间的剂量-反应关系:一项横断面研究。
Front Public Health. 2022 Dec 19;10:870568. doi: 10.3389/fpubh.2022.870568. eCollection 2022.
4
Hypertension Related to Obesity: Pathogenesis, Characteristics and Factors for Control.肥胖相关高血压:发病机制、特征及控制因素。
Int J Mol Sci. 2022 Oct 14;23(20):12305. doi: 10.3390/ijms232012305.
5
The Good, the Bad and the New about Uric Acid in Cancer.癌症中尿酸的益处、弊端与新进展
Cancers (Basel). 2022 Oct 10;14(19):4959. doi: 10.3390/cancers14194959.
6
Uric acid and blood pressure in NHANES dated from 2009 to 2018: A cross-sectional research.2009 年至 2018 年 NHANES 中的尿酸与血压:一项横断面研究。
Nutr Metab Cardiovasc Dis. 2022 Nov;32(11):2568-2578. doi: 10.1016/j.numecd.2022.08.017. Epub 2022 Aug 31.
7
Uric Acid and Hypertension: a Review of Evidence and Future Perspectives for the Management of Cardiovascular Risk.尿酸与高血压:心血管风险管理的证据回顾及未来展望。
Hypertension. 2022 Sep;79(9):1927-1936. doi: 10.1161/HYPERTENSIONAHA.122.17956. Epub 2022 Jun 6.
8
Body Mass Index (BMI): A Screening Tool Analysis.体重指数(BMI):一种筛查工具分析。
Cureus. 2022 Feb 11;14(2):e22119. doi: 10.7759/cureus.22119. eCollection 2022 Feb.
9
Postdiagnosis BMI Change Is Associated with Non-Small Cell Lung Cancer Survival.诊断后 BMI 变化与非小细胞肺癌生存有关。
Cancer Epidemiol Biomarkers Prev. 2022 Jan;31(1):262-268. doi: 10.1158/1055-9965.EPI-21-0503. Epub 2021 Nov 2.
10
HOMA-IR as a risk factor of gestational diabetes mellitus and a novel simple surrogate index in early pregnancy.胰岛素抵抗指数(HOMA-IR)作为妊娠期糖尿病的危险因素及早期妊娠一种新型的简单替代指标。
Int J Gynaecol Obstet. 2022 Jun;157(3):694-701. doi: 10.1002/ijgo.13905. Epub 2021 Sep 24.